Muffarah Hamid Alharthi
Overview
Explore the profile of Muffarah Hamid Alharthi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
80
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miskeen E, Alfaifi J, Alhuian D, Alghamdi M, Alharthi M, Alshahrani N, et al.
Int J Gen Med
. 2025 Jan;
18():237-245.
PMID: 39834911
Introduction: With the incorporation of artificial intelligence (AI), significant advancements have occurred in the field of fetal medicine, holding the potential to transform prenatal care and diagnostics, promising to revolutionize...
2.
Mohammed O, Youssef M, Hamad R, Abdel-Reheim M, Saleh L, Alamri M, et al.
PLoS One
. 2024 Oct;
19(10):e0312572.
PMID: 39480853
The development of new drugs for the inhibition of hepatocellular carcinoma (HCC) development and progression is a critical and urgent need. The median survival rate for HCC patients remains disappointingly...
3.
Alharthi M, Miskeen E, Alotaibi E, Ibrahim I, Alamri M, Alshahrani M, et al.
Healthcare (Basel)
. 2024 Aug;
12(16).
PMID: 39201233
Background: Hypertension imposes a significant public health burden. An increased awareness of hypertension complications within a population can positively impact patient care and prevent complications. This study seeks to assess...
4.
Mir M, Alfaifi J, Sohail S, Rizvi S, Akhtar M, Alghamdi M, et al.
J Pers Med
. 2024 Jul;
14(7).
PMID: 39063997
Background: Type 2 diabetes mellitus (T2DM) is becoming a major global health concern, especially in developing nations. The high prevalence of obesity and related diabetes cases are attributed to rapid...
5.
Jeelani M, Fouotsa H, Mohammed O, Alfaifi J, Adebayo S, Ahmed M, et al.
Front Pharmacol
. 2024 Jun;
15:1370073.
PMID: 38887547
There is a growing interest in studying natural products for the identification of novel lead compounds for drug development for treating inflammatory diseases. Although some studies have focused anti-inflammatory activity...
6.
Mohammed O, Youssef M, Doghish A, Hamad R, Abdel-Reheim M, Alghamdi M, et al.
Eur J Pharm Sci
. 2024 May;
198:106792.
PMID: 38714237
Non-alcoholic steatohepatitis (NASH) is characterized by liver inflammation, fat accumulation, and collagen deposition. Due to the limited availability of effective treatments, there is a pressing need to develop innovative strategies....
7.
Mohammed O, Saber S, Abdel-Reheim M, Alamri M, Alfaifi J, Adam M, et al.
Toxicol Appl Pharmacol
. 2024 Apr;
486:116943.
PMID: 38677600
Ulcerative colitis (UC) is an inflammatory condition that affects the colon's lining and increases the risk of colon cancer. Despite ongoing research, there is no identified cure for UC. The...
8.
AlShahrani A, Al-Shahrani M, Miskeen E, Alharthi M, Alamri M, Alqahtani M, et al.
Healthcare (Basel)
. 2024 Mar;
12(6).
PMID: 38540604
Background: Identifying the potential factors of depression among medical students is the first step towards academic excellence and future safe medical practice. Methods: A cross-sectional study was conducted from December...
9.
Mohammed O, Doghish A, Alamri M, Alharthi M, Alfaifi J, Adam M, et al.
Heliyon
. 2024 Mar;
10(6):e27694.
PMID: 38509956
Background: Bronchial asthma is a persistent inflammatory respiratory condition that restricts the passage of air and causes hyperresponsiveness. Chronic asthma can be classified into three categories: mild, moderate, and severe....
10.
Abdelhady R, Mohammed O, Doghish A, Hamad R, Abdel-Reheim M, Alamri M, et al.
FASEB J
. 2024 Feb;
38(4):e23480.
PMID: 38354025
Accumulating evidence suggests that dysregulation of FOXO3a plays a significant role in the progression of various malignancies, including hepatocellular carcinoma (HCC). FOXO3a inactivation, driven by oncogenic stimuli, can lead to...